1374 related articles for article (PubMed ID: 29160310)
1. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
Zhang J; Bu X; Wang H; Zhu Y; Geng Y; Nihira NT; Tan Y; Ci Y; Wu F; Dai X; Guo J; Huang YH; Fan C; Ren S; Sun Y; Freeman GJ; Sicinski P; Wei W
Nature; 2018 Jan; 553(7686):91-95. PubMed ID: 29160310
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced Colorectal Cancer Immune Escape through Stabilizing PD-L1 Expression.
Zhang H; Xia Y; Wang F; Luo M; Yang K; Liang S; An S; Wu S; Yang C; Chen D; Xu M; Cai M; To KKW; Fu L
Adv Sci (Weinh); 2021 May; 8(10):2003404. PubMed ID: 34026438
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.
Li CW; Lim SO; Xia W; Lee HH; Chan LC; Kuo CW; Khoo KH; Chang SS; Cha JH; Kim T; Hsu JL; Wu Y; Hsu JM; Yamaguchi H; Ding Q; Wang Y; Yao J; Lee CC; Wu HJ; Sahin AA; Allison JP; Yu D; Hortobagyi GN; Hung MC
Nat Commun; 2016 Aug; 7():12632. PubMed ID: 27572267
[TBL] [Abstract][Full Text] [Related]
4. Insights into the aberrant CDK4/6 signaling pathway as a therapeutic target in tumorigenesis.
Rezaeian AH; Inuzuka H; Wei W
Adv Protein Chem Struct Biol; 2023; 135():179-201. PubMed ID: 37061331
[TBL] [Abstract][Full Text] [Related]
5. BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma.
Yu Z; Wu X; Zhu J; Yan H; Li Y; Zhang H; Zhong Y; Lin M; Ye G; Li X; Jin J; Li K; Wang J; Zhuang H; Lin T; He J; Lu C; Xu Z; Zhang X; Li H; Jin X
Cell Mol Life Sci; 2024 Feb; 81(1):82. PubMed ID: 38340178
[TBL] [Abstract][Full Text] [Related]
6. Sorting nexin 6 interacts with Cullin3 and regulates programmed death ligand 1 expression.
Ghosh C; Xing Y; Li S; Hoyle RG; Sun M; Li J; Sun Y
FEBS Lett; 2021 Oct; 595(20):2558-2569. PubMed ID: 34510437
[TBL] [Abstract][Full Text] [Related]
7. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6.
Tan Y; Ci Y; Dai X; Wu F; Guo J; Liu D; North BJ; Huo J; Zhang J
Oncotarget; 2017 Jul; 8(29):47890-47901. PubMed ID: 28599312
[TBL] [Abstract][Full Text] [Related]
8. CUL3/SPOP complex prevents immune escape and enhances chemotherapy sensitivity of ovarian cancer cells through degradation of PD-L1 protein.
Dong M; Qian M; Ruan Z
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36198437
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression.
Jin X; Ding D; Yan Y; Li H; Wang B; Ma L; Ye Z; Ma T; Wu Q; Rodrigues DN; Kohli M; Jimenez R; Wang L; Goodrich DW; de Bono J; Dong H; Wu H; Zhu R; Huang H
Mol Cell; 2019 Jan; 73(1):22-35.e6. PubMed ID: 30527665
[TBL] [Abstract][Full Text] [Related]
10. Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells.
The I; Ruijtenberg S; Bouchet BP; Cristobal A; Prinsen MB; van Mourik T; Koreth J; Xu H; Heck AJ; Akhmanova A; Cuppen E; Boxem M; Muñoz J; van den Heuvel S
Nat Commun; 2015 Jan; 6():5906. PubMed ID: 25562820
[TBL] [Abstract][Full Text] [Related]
11. c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis.
Zhang L; Wang X; Li Y; Han J; Gao X; Li S; Wang F
Clin Transl Med; 2021 Sep; 11(9):e464. PubMed ID: 34586738
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of RCC1 sensitizes immunotherapy by up-regulating PD-L1 via p27
Zeng X; Zhong M; Yang Y; Wang Z; Zhu Y
J Cell Mol Med; 2021 Apr; 25(8):4136-4147. PubMed ID: 33630417
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.
Wu F; Dai X; Gan W; Wan L; Li M; Mitsiades N; Wei W; Ding Q; Zhang J
Cancer Lett; 2017 Jan; 385():207-214. PubMed ID: 27780719
[TBL] [Abstract][Full Text] [Related]
14. SPOP mutations promote tumor immune escape in endometrial cancer via the IRF1-PD-L1 axis.
Gao K; Shi Q; Gu Y; Yang W; He Y; Lv Z; Ding Y; Cao W; Wang C; Wan X
Cell Death Differ; 2023 Feb; 30(2):475-487. PubMed ID: 36481790
[TBL] [Abstract][Full Text] [Related]
15. Neddylation inhibition upregulates PD-L1 expression and enhances the efficacy of immune checkpoint blockade in glioblastoma.
Zhou S; Zhao X; Yang Z; Yang R; Chen C; Zhao K; Wang W; Ma Y; Zhang Q; Wang X
Int J Cancer; 2019 Aug; 145(3):763-774. PubMed ID: 31044422
[TBL] [Abstract][Full Text] [Related]
16. Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1.
Li C; Ao J; Fu J; Lee DF; Xu J; Lonard D; O'Malley BW
Oncogene; 2011 Oct; 30(42):4350-64. PubMed ID: 21577200
[TBL] [Abstract][Full Text] [Related]
17. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
[TBL] [Abstract][Full Text] [Related]
18. The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D.
Chaikovsky AC; Li C; Jeng EE; Loebell S; Lee MC; Murray CW; Cheng R; Demeter J; Swaney DL; Chen SH; Newton BW; Johnson JR; Drainas AP; Shue YT; Seoane JA; Srinivasan P; He A; Yoshida A; Hipkins SQ; McCrea E; Poltorack CD; Krogan NJ; Diehl JA; Kong C; Jackson PK; Curtis C; Petrov DA; Bassik MC; Winslow MM; Sage J
Nature; 2021 Apr; 592(7856):794-798. PubMed ID: 33854239
[TBL] [Abstract][Full Text] [Related]
19. TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer.
Dai X; Wu Z; Ruan R; Chen J; Huang C; Lei W; Yao Y; Li L; Tang X; Xiong J; Feng M; Deng J
Cell Commun Signal; 2024 Mar; 22(1):168. PubMed ID: 38454413
[TBL] [Abstract][Full Text] [Related]
20. ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation.
Wu Y; Zhang C; Liu X; He Z; Shan B; Zeng Q; Zhao Q; Zhu H; Liao H; Cen X; Xu X; Zhang M; Hou T; Wang Z; Yan H; Yang S; Sun Y; Chen Y; Wu R; Xie T; Chen W; Najafov A; Ying S; Xia H
Nat Commun; 2021 Apr; 12(1):2346. PubMed ID: 33879767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
